documents: FDA-2024-N-3533-0001
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2024-N-3533-0001 | FDA | FDA-2024-N-3533 | Microbiology Devices; Reclassification of Antigen, Antibody, and Nucleic Acid-Based Hepatitis B Virus Assay Devices | Proposed Rule | Request for Comment | 2024-09-25T04:00:00Z | 2024 | 9 | 2024-09-25T04:00:00Z | 2024-11-26T04:59:59Z | 2024-11-26T02:00:30Z | 2024-21932 | 0 | 0 | 0900006486782c1a |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref